Exam 2 - Genetic testing and Gene therapy Flashcards

Genetic testing and Gene therapy

You may prefer our related Brainscape-certified flashcards:
1
Q

Goal of screening

A

Early identification of a disorder so that intervention can prevent or reverse the disease process

Assist in reproductive decisions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Determines the genotypes in individuals that:

A

1) Already have a disease or predisposed to a disease
e. g. newborn screening
2) Are presymptomatic for a disease
e. g. Huntington disease, breast cancer, colon cancer

3) May have a disease genes that could be passed down to descendants
e. g. Fragile X gene in carrier females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Parameters for genetic screening tests:

A

Validity
Specificity
Sensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Validity

A

Refers to the ability of a test to separate individuals who have the disease from those who do not.

Validity involves 2 components: sensitivity and specificity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sensitivity

A

the ability to correctly identify those with the disease . It is measured as the proportion of affected individuals who test positive (i.e. true positives)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Specificity

A

ability to correctly identify those without the disease. It is measured as the proportion of unaffected individuals in whom the test is negative (i.e. true negatives)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

_____ and _____ are determined by comparing the screening results with those of a _____ diagnostic test

A

Sensitivity
specificity
definitive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Test result vs true status

A

(true status)
+ -
(test) + A B

        -    C     D
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sensitivity (calc)

A

a/a+c

Probability that test is positive when person actually has the disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Specificity (calc)

A

d/b+d

Probability that test is negative when person truly does NOT has the disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

False Positive

A

b/b+d

Test reports positive for person who does NOT have the disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

False Negative

A

c/a+c

Test reports negative for person who actually has the disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

High ____ value results in high ____

A

“a”

sensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

High ____ value results in high ____

A

“d”

specificity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

PPV

A

Positive Predictive value

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Positive Predictive value

A
  • Proportion of positive test results that are truly positive
  • answers the question: if my test is positive, what is the chance that I am truly positive for the condition?
  • a/a+b
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

NPV

A

Negative Predictive value

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Negative Predictive value

A

Proportion of negative test results that are truly negative

Answers the question: if my test is negative, what is the chance that I am truly unaffected??

d/c+d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

____ of a test varies based on _____ of the condition in a given pop

A

PPV

prevalence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

The ____ the condition in a given pop, lower the ____

A

rarer

PPV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

More detailed PPV calculation

A

Sensitivity x prevalence
(divided by)
(sensitivity x prevalence) + (1-specificy) (1-prevalence)

22
Q

In trying to cast a wider net to catch more patients, the trade off is having __________

A

increased false-positive rate

23
Q

Screening tests are never 100% ____ and 100% ____.

A

sensitive

specific

24
Q

non- invasive pre-natal screening methods:

A
Ultrasound 
Nuchal Translucency Index
Maternal Serum screening 
Triple screen; quad screen 
Fetal cells 
Cell free fetal DNA
25
Q

Invasive pre-natal diagnostic methods:

A

Amniocentesis
Chorionic Villus Sampling (CVS)
Percutaneous Umbilical Blood Sampling

26
Q

Ultrasound

A

Can be used to determine presence of spina bifida (meningomyelocele) displayed as a fluid filled sac in the spinal column

27
Q

Nuchal Translucency Index

A

Uses ultrasound to measure the translucent space in the tissue at the back of your developing baby’s neck.

28
Q

Nuchal Translucency Index used to determine:

A

baby’s risk for Down syndrome (DS) and other chromosomal abnormalities, as well as major congenital heart problems.

29
Q

Babies with abnormalities tend to accumulate more:

A

fluid at the back of their neck during the first trimester. Result is an enlargement in this region

30
Q

US vs Sonogram

A

US - the machine that allows you to see your baby during your pregnancy

Sonogram - the picture taken of your baby during the ultrasound.

31
Q

______ take _____ images, or 3D sonograms, and adds the element of time to the process.

A

4D Ultrasounds

3D Ultrasound

32
Q

In prenatal screening, confirmation of a _____ result should be followed up with _____

A

positive

diagnostic testing

33
Q

Amniocentesis

A

20-30 mL of amniotic fluid is withdrawn transabdominally with US guidance

34
Q

Amniocentesis usually occurs:

A

15-17 weeks gestation

35
Q

CVS procedure:

A

a catheter is inserted through the cervix and several mg of villus tissue is suctioned with US guidance

36
Q

Fetal treatment is _____

A

rare

37
Q

Fetal treatment used in the following 3 conditions:

A

Congenital Adrenal Hyperplasia
Biotin-responsive Multiple Carboxylase Deficiency
fetal surgery for a neural tube disorder

38
Q

In NBS, _____ screen results need to be followed up with further _______ that is specific for _________

A

Positive
confirmation testing
each condition identified

39
Q

Methods of DNA analysis of biosamples:

A

PCR
ASO (allele specific oligonucleotide) using dot blot
DNA sequencing
Many other methods

40
Q

allele specific oligonucleotide used frequently for:

A

Sickle cell and cystic fibrosis

41
Q

_________ Is the UltimateWay to Characterize a Clone

A

DNA Sequencing

42
Q

DNA that you saturate the filter paper with (ASO method)

A

Probe

43
Q

Antisense strand

A

Sample DNA from patient that complements either prode

44
Q

Based off how the hybridization occurs in ASO:

A

You can tell whether patient is homozygous normal, a carrier, or diseased

45
Q

Newer methods of sequencing associated with Next Generation Sequencing (NGS):

A

Pyrophosphate sequencing

46
Q

DNA sequencing by the _______ developed by _____

A

chain termination method

Sanger

47
Q

Pyrophosphate sequencing relies on the “___________” principle rather than chain termination

A

sequencing by synthesis

48
Q

Pyrophosphate sequencing step 1:

A

ss DNA template is immobilized, and solutions of A, C, G, and T nucleotides are added sequentially to allow for synthesis of complementary strand. Unattached nucleotides are washed off

49
Q

Pyrophosphate sequencing step 2:

A

Light is emitted when the nucleotide attaches to template. The sequence of light signals allows determination of DNA template sequence.

50
Q

ATPs role in Pyrophosphate sequencing

A

ATP acts as fuel for luciferase-mediated conversion of luciferin to oxyluciferin that generates visible light in amounts that are proportional to the amount of ATP.

51
Q

How is light captured in Pyrophosphate sequencing

A

Light produced in the luciferase-catalyzed reaction is detected by a camera/scanner